{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T12:53:48Z","timestamp":1787662428333,"version":"build-2736575974"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T00:00:00Z","timestamp":1719964800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T00:00:00Z","timestamp":1719964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"DOI":"10.1007\/s00192-024-05844-x","type":"journal-article","created":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T13:03:09Z","timestamp":1720011789000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["How Intravesical  Platelet-Rich Plasma  Can Help Patients with Interstitial Cystitis\/Bladder Pain Syndrome: A Comprehensive Scoping Review"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3964-3778","authenticated-orcid":false,"given":"Ahmed","family":"Soliman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Adel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Elnagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saif","family":"Elsonbaty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed El","family":"Hefnawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,3]]},"reference":[{"key":"5844_CR1","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/iju.14234","volume":"27","author":"Y Homma","year":"2020","unstructured":"Homma Y, Akiyama Y, Tomoe H, et al. Clinical guidelines for interstitial cystitis\/bladder pain syndrome. Int J Urol. 2020;27:578\u201389. https:\/\/doi.org\/10.1111\/iju.14234.","journal-title":"Int J Urol"},{"key":"5844_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0198816","volume":"13","author":"J-F Jhang","year":"2018","unstructured":"Jhang J-F, Ho H-C, Jiang Y-H, et al. Electron microscopic characteristics of interstitial cystitis\/bladder pain syndrome and their association with clinical condition. PLoS One. 2018;13: e0198816. https:\/\/doi.org\/10.1371\/journal.pone.0198816.","journal-title":"PLoS On"},{"key":"5844_CR3","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s00192-011-1546-5","volume":"23","author":"D Porru","year":"2012","unstructured":"Porru D, Leva F, Parmigiani A, et al. Impact of intravesical hyaluronic acid and chondroitin sulfate on bladder pain syndrome\/interstitial cystitis. Int Urogynecol J. 2012;23:1193\u20139. https:\/\/doi.org\/10.1007\/s00192-011-1546-5.","journal-title":"Int Urogynecol J"},{"key":"5844_CR4","first-page":"1454","volume":"9","author":"G Steinhoff","year":"2002","unstructured":"Steinhoff G, Ittah B, Rowan S. The efficacy of chondroitin sulfate 0.2% in treating interstitial cystitis. Can J Urol. 2002;9:1454\u20138.","journal-title":"Can J Urol"},{"key":"5844_CR5","doi-asserted-by":"publisher","first-page":"871","DOI":"10.3390\/toxins14120871","volume":"14","author":"W-R Yu","year":"2022","unstructured":"Yu W-R, Jiang Y-H, Jhang J-F, et al. Treatment outcomes of intravesical botulinum toxin A injections on patients with interstitial cystitis\/bladder pain syndrome. Toxins (Basel) 2022;14:871. https:\/\/doi.org\/10.3390\/toxins14120871","journal-title":"Toxins (Basel)"},{"key":"5844_CR6","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1007\/s00192-019-03898-w","volume":"30","author":"A Mahran","year":"2019","unstructured":"Mahran A, Baaklini G, Hassani D, et al. Sacral neuromodulation treating chronic pelvic pain: a meta-analysis and systematic review of the literature. Int Urogynecol J. 2019;30:1023\u201335. https:\/\/doi.org\/10.1007\/s00192-019-03898-w.","journal-title":"Int Urogynecol J"},{"key":"5844_CR7","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3109\/09537104.2016.1143922","volume":"27","author":"F Mussano","year":"2016","unstructured":"Mussano F, Genova T, Munaron L, et al. Cytokine, chemokine, and growth factor profile of platelet-rich plasma. Platelets. 2016;27:467\u201371. https:\/\/doi.org\/10.3109\/09537104.2016.1143922.","journal-title":"Platelets"},{"key":"5844_CR8","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s12035-013-8494-7","volume":"48","author":"DP Kuffler","year":"2013","unstructured":"Kuffler DP. Platelet-rich plasma and the elimination of neuropathic pain. Mol Neurobiol. 2013;48:315\u201332. https:\/\/doi.org\/10.1007\/s12035-013-8494-7.","journal-title":"Mol Neurobiol"},{"key":"5844_CR9","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1097\/MS9.0000000000001615","volume":"86","author":"S Khalid","year":"2024","unstructured":"Khalid S, Ali A, Deepak F, et al. Comparative effectiveness of intra-articular therapies in knee osteoarthritis: a meta-analysis comparing platelet-rich plasma (PRP) with other treatment modalities. Ann Med Surg (Lond). 2024;86:361\u201372. https:\/\/doi.org\/10.1097\/MS9.0000000000001615.","journal-title":"Ann Med Surg (Lond)"},{"key":"5844_CR10","doi-asserted-by":"publisher","DOI":"10.1093\/sxmrev\/qeae018","author":"M Deabes","year":"2024","unstructured":"Deabes M, Deameh MG, Bani Irshid BA, et al. Evaluating the efficacy and safety of platelet-rich plasma injection for erectile dysfunction: a systematic review and meta-analysis of randomized controlled trials. Sex Med Rev. 2024. https:\/\/doi.org\/10.1093\/sxmrev\/qeae018.","journal-title":"Sex Med Rev"},{"key":"5844_CR11","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.3390\/biomedicines11112919","volume":"11","author":"I Dankova","year":"2023","unstructured":"Dankova I, Pyrgidis N, Tishukov M, et al. Efficacy and safety of platelet-rich plasma injections for the treatment of female sexual dysfunction and stress urinary incontinence: a systematic review. Biomedicines 2023;11:2919. https:\/\/doi.org\/10.3390\/biomedicines11112919","journal-title":"Biomedicines"},{"key":"5844_CR12","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1002\/nau.23898","volume":"38","author":"J-F Jhang","year":"2019","unstructured":"Jhang J-F, Lin T-Y, Kuo H-C. Intravesical injections of platelet-rich plasma is effective and safe in treatment of interstitial cystitis refractory to conventional treatment\u2014a prospective clinical trial. Neurourol Urodyn. 2019;38:703\u20139. https:\/\/doi.org\/10.1002\/nau.23898.","journal-title":"Neurourol Urodyn"},{"key":"5844_CR13","doi-asserted-by":"publisher","first-page":"15218","DOI":"10.1038\/s41598-020-72292-0","volume":"10","author":"Y-H Jiang","year":"2020","unstructured":"Jiang Y-H, Kuo Y-C, Jhang J-F, et al. Repeated intravesical injections of platelet-rich plasma improve symptoms and alter urinary functional proteins in patients with refractory interstitial cystitis. Sci Rep. 2020;10:15218. https:\/\/doi.org\/10.1038\/s41598-020-72292-0.","journal-title":"Sci Rep"},{"key":"5844_CR14","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1471-2288-13-48","volume":"13","author":"HML Daudt","year":"2013","unstructured":"Daudt HML, van Mossel C, Scott SJ. Enhancing the scoping study methodology: a large, inter-professional team\u2019s experience with Arksey and O\u2019Malley\u2019s framework. BMC Med Res Methodol. 2013;13:48. https:\/\/doi.org\/10.1186\/1471-2288-13-48.","journal-title":"BMC Med Res Methodol"},{"key":"5844_CR15","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/s0090-4295(99)80334-3","volume":"49","author":"LJ Simon","year":"1997","unstructured":"Simon LJ, Landis JR, Erickson DR, Nyberg LM. The Interstitial Cystitis Data Base Study: concepts and preliminary baseline descriptive statistics. Urology. 1997;49:64\u201375. https:\/\/doi.org\/10.1016\/s0090-4295(99)80334-3.","journal-title":"Urology"},{"key":"5844_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.853776","volume":"13","author":"Y-H Jiang","year":"2022","unstructured":"Jiang Y-H, Jhang J-F, Lin T-Y, et al. Therapeutic efficacy of intravesical platelet-rich plasma injections for interstitial cystitis\/bladder pain syndrome\u2014a comparative study of different injection number, additives and concentrations. Front Pharmacol. 2022;13:853776. https:\/\/doi.org\/10.3389\/fphar.2022.853776.","journal-title":"Front Pharmacol"},{"key":"5844_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/CU9.0000000000000156","volume":"18","author":"AS El Hefnawy","year":"2024","unstructured":"El Hefnawy AS, Hasan MAA, El Sawy E, et al. Intravesical instillation of platelet-rich plasma for treatment of interstitial cystitis\/bladder pain syndrome: a pilot study. Curr Urol. 2024;18:49\u201354. https:\/\/doi.org\/10.1097\/CU9.0000000000000156.","journal-title":"Curr Urol"},{"key":"5844_CR18","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.5213\/inj.2142100.050","volume":"26","author":"J-F Jhang","year":"2022","unstructured":"Jhang J-F, Jiang Y-H, Hsu Y-H, et al. Improved urothelial cell proliferation, cytoskeleton and barrier function protein expression in the patients with interstitial cystitis\/bladder pain syndrome after intravesical platelet-rich plasma injection. Int Neurourol J. 2022;26:S57\u201367. https:\/\/doi.org\/10.5213\/inj.2142100.050.","journal-title":"Int Neurourol J"},{"key":"5844_CR19","doi-asserted-by":"publisher","first-page":"O42","DOI":"10.1111\/luts.12212","volume":"11","author":"J-F Jhang","year":"2019","unstructured":"Jhang J-F, Wu S-Y, Lin T-Y, Kuo H-C. Repeated intravesical injections of platelet-rich plasma are effective in the treatment of interstitial cystitis: a case control pilot study. Low Urin Tract Symptoms. 2019;11:O42\u20137. https:\/\/doi.org\/10.1111\/luts.12212.","journal-title":"Low Urin Tract Symptoms"},{"key":"5844_CR20","doi-asserted-by":"publisher","first-page":"e22747","DOI":"10.7759\/cureus.22747","volume":"14","author":"TJ Hardy","year":"2022","unstructured":"Hardy TJ. Interstitial cystitis can be improved with intravesical instillation of platelet-rich plasma. Cureus. 2022;14:e22747. https:\/\/doi.org\/10.7759\/cureus.22747.","journal-title":"Cureus"},{"key":"5844_CR21","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3390\/toxins15020121","volume":"15","author":"J-F Jhang","year":"2023","unstructured":"Jhang J-F, Yu W-R, Kuo H-C. Comparison of the clinical efficacy and adverse events between intravesical injections of platelet-rich plasma and botulinum toxin A for the treatment of interstitial cystitis refractory to conventional treatment. Toxins (Basel). 2023;15:121. https:\/\/doi.org\/10.3390\/toxins15020121","journal-title":"Toxins (Basel)"},{"key":"5844_CR22","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.3390\/biomedicines10051182","volume":"10","author":"Y-K Lee","year":"2022","unstructured":"Lee Y-K, Jiang Y-H, Jhang J-F, et al. Changes in the ultrastructure of the bladder urothelium in patients with interstitial cystitis after intravesical injections of platelet-rich plasma. Biomedicines. 2022;10:1182. https:\/\/doi.org\/10.3390\/biomedicines10051182","journal-title":"Biomedicines"},{"key":"5844_CR23","doi-asserted-by":"publisher","first-page":"609","DOI":"10.22037\/uj.v0i0.5239","volume":"16","author":"M Mirzaei","year":"2019","unstructured":"Mirzaei M, Daneshpajooh A, Farsinezhad A, et al. The therapeutic effect of intravesical instillation of platelet rich plasma on recurrent bacterial cystitis in women: a randomized clinical trial. Urol J 16:609\u2013613. https:\/\/doi.org\/10.22037\/uj.v0i0.5239","journal-title":"Urol J"},{"key":"5844_CR24","doi-asserted-by":"publisher","first-page":"154","DOI":"10.4274\/tjod.galenos.2023.46588","volume":"20","author":"A Soliman","year":"2023","unstructured":"Soliman A, Elsonbaty S, Saleh Y, et al. How autologous platelet-rich plasma affects pregnancy and birth outcomes in women with repeated embryo implantation failure: a PRISMA-compliant meta-analysis. Turk J Obstet Gynecol. 2023;20:154\u201363. https:\/\/doi.org\/10.4274\/tjod.galenos.2023.46588.","journal-title":"Turk J Obstet Gynecol"},{"key":"5844_CR25","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1038\/s41598-018-19419-6","volume":"8","author":"J Etulain","year":"2018","unstructured":"Etulain J, Mena HA, Meiss RP, et al. An optimised protocol for platelet-rich plasma preparation to improve its angiogenic and regenerative properties. Sci Rep. 2018;8:1513. https:\/\/doi.org\/10.1038\/s41598-018-19419-6.","journal-title":"Sci Rep"},{"key":"5844_CR26","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/scrt218","volume":"4","author":"PR Amable","year":"2013","unstructured":"Amable PR, Carias RBV, Teixeira MVT, et al. Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factors. Stem Cell Res Ther. 2013;4:67. https:\/\/doi.org\/10.1186\/scrt218.","journal-title":"Stem Cell Res Ther"},{"key":"5844_CR27","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1006\/exnr.1999.7254","volume":"161","author":"MA Vizzard","year":"2000","unstructured":"Vizzard MA. Changes in urinary bladder neurotrophic factor mRNA and NGF protein following urinary bladder dysfunction. Exp Neurol. 2000;161:273\u201384. https:\/\/doi.org\/10.1006\/exnr.1999.7254.","journal-title":"Exp Neurol"},{"key":"5844_CR28","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/luts.12364","volume":"13","author":"Y-H Jiang","year":"2021","unstructured":"Jiang Y-H, Jhang J-F, Hsu Y-H, et al. Urothelial health after platelet-rich plasma injection in intractable recurrent urinary tract infection: improved cell proliferation, cytoskeleton, and barrier function protein expression. Low Urin Tract Symptoms. 2021;13:271\u20138. https:\/\/doi.org\/10.1111\/luts.12364.","journal-title":"Low Urin Tract Symptoms"},{"key":"5844_CR29","doi-asserted-by":"publisher","first-page":"F540","DOI":"10.1152\/ajprenal.2000.278.4.F540","volume":"278","author":"JP Lavelle","year":"2000","unstructured":"Lavelle JP, Meyers SA, Ruiz WG, et al. Urothelial pathophysiological changes in feline interstitial cystitis: a human model. Am J Physiol Renal Physiol. 2000;278:F540\u201353. https:\/\/doi.org\/10.1152\/ajprenal.2000.278.4.F540.","journal-title":"Am J Physiol Renal Physiol"}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-024-05844-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00192-024-05844-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-024-05844-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T13:03:58Z","timestamp":1720011838000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00192-024-05844-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,3]]},"references-count":29,"alternative-id":["5844"],"URL":"https:\/\/doi.org\/10.1007\/s00192-024-05844-x","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"value":"0937-3462","type":"print"},{"value":"1433-3023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,3]]},"assertion":[{"value":"11 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There is nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure Statements"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics of Approval Statement"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient Consent Statement"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial Registration"}}]}}